亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Cardiac resynchronization therapy in heart failure based on Strauss criteria for left bundle branch block

左束支阻滞 医学 心脏再同步化治疗 内科学 心脏病学 心力衰竭 束支阻滞 心肌病 心电图 射血分数
作者
Athanasios Saplaouras,Konstantinos Vlachos,Panagiotis Mililis,Athena Batsouli,George Bazoukis,Sotirios Xydonas,Panagioula Niarchou,Antonio Frontera,Stylianos Dragasis,Ourania Kariki,Ilias G. Patsiotis,Aggeliki Gkouziouta,Panagiotis Stachteas,Panagiotis Korantzopoulos,Stylianos Tzeis,Nikolaos Fragakis,Michael Efremidis,Κonstantinos P. Letsas
出处
期刊:Esc Heart Failure [Wiley]
标识
DOI:10.1002/ehf2.15028
摘要

Abstract Aims The left bundle branch block (LBBB) is a strong predictor of response to cardiac resynchronization therapy (CRT). However, a significant number of patients do not respond to the treatment. The study sought to evaluate the impact of the stricter Strauss criteria for left bundle branch block (St‐LBBB) on CRT response, hospitalizations, ventricular arrhythmia (VA) events and mortality. Methods This study is a retrospective analysis of prospectively collected data on heart failure (HF) patients with LBBB admitted for CRT implantation. Patients were divided into two groups according to the fulfilment or not of St‐LBBB criteria. Results The study included 82 patients with ischaemic (ICM) and non‐ischaemic (NICM) cardiomyopathy [46 (56%) with St‐LBBB and 36 (44%) with non‐St‐LBBB]. Patients with St‐LBBB showed higher CRT response rates compared with those with non‐St‐LBBB ( P < 0.01), while the group with NICM exhibited the greatest benefit ( P < 0.01). St‐LBBB CRT responders displayed significantly lower rates of HF hospitalization ( P < 0.0001) compared with the non‐St‐LBBB group. According to Kaplan–Meier time curves, this was primarily evident in patients with NICM ( P < 0.0001). CRT responders displayed significantly fewer VA events ( P < 0.001) and lower mortality rates ( P < 0.0001) than non‐responders. Kaplan–Meier estimates demonstrated a significantly lower incidence of VAs in NICM patients with St‐LBBB ( P = 0.049) compared with ICM patients with St‐LBBB ( P = 0.25). Lower mortality rates were observed in CRT responders than non‐responders ( P < 0.0001), with the group of NICM with St‐LBBB criteria exhibiting the greatest benefit ( P = 0.0238). Conclusions Patients with NICM and St‐LBBB present the greatest benefit concerning CRT response, HF hospitalizations, VA events and mortality. Although St‐LBBB criteria seem to improve patient selection for CRT, more data are needed to elucidate the role of St‐LBBB criteria in this setting.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
chenchen完成签到,获得积分10
30秒前
du完成签到 ,获得积分10
30秒前
开心惜梦完成签到,获得积分10
1分钟前
1分钟前
1分钟前
maprang完成签到,获得积分10
1分钟前
学生信的大叔完成签到,获得积分10
1分钟前
orixero应助qigao采纳,获得10
1分钟前
2分钟前
qigao发布了新的文献求助10
2分钟前
2分钟前
3分钟前
3分钟前
小二郎应助ratamatahara采纳,获得10
3分钟前
斯文败类应助科研通管家采纳,获得10
3分钟前
qigao完成签到,获得积分10
3分钟前
3分钟前
7777777发布了新的文献求助10
4分钟前
李健应助英俊皮皮虾采纳,获得10
4分钟前
FFFFcom完成签到,获得积分10
4分钟前
爱听歌电灯胆完成签到 ,获得积分10
4分钟前
4分钟前
4分钟前
5分钟前
5分钟前
5分钟前
ratamatahara发布了新的文献求助10
5分钟前
脑洞疼应助wuu采纳,获得10
6分钟前
竹青应助科研通管家采纳,获得10
7分钟前
7分钟前
9分钟前
香蕉剑成发布了新的文献求助10
9分钟前
脆蜜金桔应助科研通管家采纳,获得10
9分钟前
GrindSeason完成签到,获得积分10
9分钟前
Jasper应助ratamatahara采纳,获得10
9分钟前
Lucas应助坚果燕麦采纳,获得10
9分钟前
香蕉剑成完成签到,获得积分10
9分钟前
9分钟前
坚果燕麦发布了新的文献求助10
10分钟前
Akim应助坚果燕麦采纳,获得10
10分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
The Organometallic Chemistry of the Transition Metals 800
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
Signals, Systems, and Signal Processing 610
The formation of Australian attitudes towards China, 1918-1941 600
Research Methods for Business: A Skill Building Approach, 9th Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6418750
求助须知:如何正确求助?哪些是违规求助? 8238333
关于积分的说明 17501913
捐赠科研通 5471647
什么是DOI,文献DOI怎么找? 2890740
邀请新用户注册赠送积分活动 1867541
关于科研通互助平台的介绍 1704558